Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

publicerad i: Proceedings of the National Academy of Sciences

utgivningsår: 1998-09-29

språk: engelska

Refererar artiklar 41

Datum

Titel

Författare

1998-02-01

Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity
1998-02-01

Protein kinase inhibitors: the tyrosine-specific protein kinases
1998-01-01

Specificity within the EGF family/ErbB receptor family signaling network
1997-08-01

Bivalence of EGF-like ligands drives the ErbB signaling network

Gil Levkowitz
1997-04-01

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
1997-10-01

Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor
1997-08-01

Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
1997-02-01

Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation

Mark A. Lemmon
1997-01-01

HER-2/neu signal transduction in human breast and ovarian cancer
1997-03

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases
1997-01-01

EGF-R expression in ductal breast cancer: proliferation and prognostic implications

Igea D'Agnano
1997-05-01

Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of binding
1997-08-01

Effects of sulfhydryl modification reagents on the kinase activity of the epidermal growth factor receptor
1997-11-01

Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase
1996-05-15

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions
1996-10-01

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma

Maria Gabriella Ferrandina
1996-10-01

Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice
1996-02-01

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
1996-01-01

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor
1996-11-01

Identification of nitration sites on surfactant protein A by tandem electrospray mass spectrometry

Kenneth D. Greis
1995-12-01

Inhibitors of protein tyrosine kinases
1995-03-01

Tyrosine kinase inhibition: an approach to drug development
1995-08-01

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy

Maria Gabriella Ferrandina
1995-01-01

Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation
1995-04-01

EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value
1994-07-01

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling
1994-01-01

The type I growth factor receptors in human breast cancer
1994-08-01

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
1994-08-01

Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activity
1994-01-01

Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study
1994-01-01

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study
1993-06-01

Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor

Artikel - wd:Q28368986

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer